Van ECK Associates Corp Buys 175,290 Shares of LanzaTech Global, Inc. (NASDAQ:LNZA)

Van ECK Associates Corp boosted its stake in shares of LanzaTech Global, Inc. (NASDAQ:LNZA) by 52.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 510,257 shares of the company’s stock after purchasing an additional 175,290 shares during the period. Van ECK Associates Corp’s holdings in LanzaTech Global were worth $2,567,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in LNZA. Vanguard Group Inc. raised its stake in LanzaTech Global by 1,631.0% during the 3rd quarter. Vanguard Group Inc. now owns 5,915,847 shares of the company’s stock valued at $27,627,000 after buying an additional 5,574,089 shares during the last quarter. Invesco Ltd. lifted its holdings in LanzaTech Global by 14,760.6% in the third quarter. Invesco Ltd. now owns 1,565,569 shares of the company’s stock valued at $7,311,000 after acquiring an additional 1,555,034 shares during the period. Dumac Inc. purchased a new position in LanzaTech Global in the third quarter worth about $4,899,000. Healthcare of Ontario Pension Plan Trust Fund bought a new stake in shares of LanzaTech Global during the 3rd quarter valued at about $780,000. Finally, Green Alpha Advisors LLC increased its position in shares of LanzaTech Global by 80.9% during the 4th quarter. Green Alpha Advisors LLC now owns 115,872 shares of the company’s stock valued at $583,000 after purchasing an additional 51,821 shares during the last quarter. Hedge funds and other institutional investors own 17.76% of the company’s stock.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. TD Cowen started coverage on shares of LanzaTech Global in a research report on Tuesday. They set a “hold” rating and a $3.00 target price for the company. Roth Mkm restated a “buy” rating and issued a $6.00 price objective on shares of LanzaTech Global in a research note on Monday, March 25th. Finally, Seaport Res Ptn reaffirmed a “buy” rating on shares of LanzaTech Global in a report on Friday, March 15th.

LanzaTech Global Price Performance

Shares of NASDAQ:LNZA opened at $2.74 on Wednesday. The company has a market capitalization of $537.81 million, a P/E ratio of -2.91 and a beta of 1.58. LanzaTech Global, Inc. has a 1-year low of $1.86 and a 1-year high of $8.70. The firm’s 50 day simple moving average is $2.92 and its two-hundred day simple moving average is $3.81. The company has a debt-to-equity ratio of 0.17, a current ratio of 6.22 and a quick ratio of 6.22.

LanzaTech Global (NASDAQ:LNZA) last released its earnings results on Wednesday, February 28th. The company reported ($0.09) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.01. LanzaTech Global had a negative net margin of 214.11% and a negative return on equity of 95.22%. The company had revenue of $20.46 million for the quarter, compared to analysts’ expectations of $36.50 million. Research analysts expect that LanzaTech Global, Inc. will post -0.43 EPS for the current fiscal year.

Insider Transactions at LanzaTech Global

In related news, insider Freya Burton sold 50,225 shares of LanzaTech Global stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $3.24, for a total transaction of $162,729.00. Following the sale, the insider now owns 39,846 shares of the company’s stock, valued at approximately $129,101.04. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

About LanzaTech Global

LanzaTech Global, Inc operates as a nature-based carbon refining company in the United States and internationally. The company transforms waste carbon into the chemical building blocks for consumer goods, such as sustainable fuels, fabrics, and packaging. It is also developing biocatalysts and processes to produce a suite of additional products utilizing novel biocatalysts, including acetone and isopropanol (IPA) and industrial solvents used in various applications, including production of polymers from IPA.